(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202412 | 202312 | % Var | 202412 | 202312 | % Var | 202403 | 202303 | % Var | |
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.09 | 0.00 | 0.00 | 0.09 | 0.00 | 0.00 | 0.00 | 0.21 | 0.00 |
| PBIDT | -2.47 | -0.19 | 1200.00 | -2.78 | -0.50 | 456.00 | -0.97 | -1.65 | -41.21 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDT | -2.47 | -0.19 | 1200.00 | -2.78 | -0.50 | 456.00 | -0.97 | -1.65 | -41.21 |
| Depreciation | 0.02 | 0.01 | 100.00 | 0.05 | 0.03 | 66.67 | 0.05 | 0.06 | -16.67 |
| PBT | -2.49 | -0.20 | 1145.00 | -2.83 | -0.53 | 433.96 | -1.02 | -1.71 | -40.35 |
| TAX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PAT | -2.49 | -0.20 | 1145.00 | -2.83 | -0.53 | 433.96 | -1.02 | -1.71 | -40.35 |
| Equity | 42.74 | 42.74 | 0.00 | 42.74 | 42.74 | 0.00 | 42.74 | 42.74 | 0.00 |
| PBIDTM(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1619.95 |
| Dr. Reddys Lab | 1315.85 |
| Cipla | 1294.75 |
| Zydus Lifesciences | 927.15 |
| Lupin | 2296.10 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: